Health

Pfizer antiretroviral vaccine is effective in studying what it means for children

Pfizer antiretroviral vaccine is effective in studying what it means for children

Pfizer said that the retrovirus vaccine given to pregnant women stopped 70% of the severe symptoms of the disease in infants during pregnancy in the first six months of life.

The company will apply for FDA approval later this year, and experts say the vaccine could be available as early as next year.

Scientists are making progress in developing a vaccine against respiratory syncytial virus, which is the main cause of hospitalization in infants.

On Tuesday, Pfizer announced that the novel coronavirus vaccine, administered to pregnant women, was 70% effective in preventing severe novel coronavirus in infants from birth to the first six months of life.

The company plans to seek approval from the FDA at a later date. This year. The news comes at a time when heart rates are increasing across the country, especially in young children.

Although the novel coronavirus often causes bronchial problems, runny nose and dry cough, it can become severe and lead to pneumonia or a type of pneumonia called bronchiolitis in high-risk groups such as infants and the elderly. New research on coronavirus vaccines for children and adults

Research centers are working on further research on possible coronavirus vaccines.

Pfizer

A recent clinical trial funded by AstraZeneca

It found that one of the 75 vaccine candidates was effective in preventing infections requiring hospitalization in infants.

Clinical trials have also shown that novel coronavirus vaccines are highly effective in the elderly and pregnant women (who can transmit antibodies to their fetus through the placenta). Since the evidence is so promising, health experts say it won’t be long before we get a reaction

The vaccine is ready for use. “High-risk adults are likely to receive multiple approved coronavirus vaccines within a year,”

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button